Intratumoral Copper as an Immunotherapy Strategy

Published Di Zheng on Fri, 06/02/2023 - 11:33

Every Monday from 1pm – 2pm notable cancer researchers, clinicians, nurses and other experts from around the globe share their insights, research or news on a broad range of topics at the VCCC Alliance Monday Lunch Live forum.

The following area contains all our recordings from 2020. 


Targeting Intratumoral Copper as a Novel Immunotherapy Strategy

Monday Lunch Live

With Dr Orazio Vittorio

12 October 2020


Blocking copper uptake in tumour cells may be a clue to boosting immune system - fighting the deadliest of cancers

The Metal-Targeted Therapy and Immunology Lab at the Children's Cancer Institute NSW has identified a strong connection between copper transporters found in malignant cancer tissue compared with normal tissue (copper transporter 1 CTR-1 and PD-L1). Their cutting-edge research is the first to prove that chelation therapy enhances anti-tumour immune responses and could be repurposed for immune checkpoint inhibition.

Dr Vittorio presents crucial evidence from their research using an FDA-approved copper chelator to increase tumour infiltrating immune cells and improve the survival in a neuroblastoma immunocompetent mouse model.


Dr Orazio Vittorio
University of New South Wales, Children's Cancer Institute

Dr Vittorio is a NHMRC Career Development Fellow and Scientia Senior Lecturer with the Faculty of Medicine at the University of New South Wales. He is head of the Metal-Targeted Therapy and Immunology Lab at the Children's Cancer Institute. Dr Vittorio is cancer biologist with ten years of post-doctoral experience and an emerging international reputation in the development of anti-cancer therapeutics. He consistently publishes research that is highly influential. Dr Vittorio has published more than 84 papers in international journals, six book chapters and four patents.

Course Details

Banner Blue Triangles
Course type
Webinars
Duration
60 mins
Price
$0.00
Curriculum Area
Research (incl. Clinical Trials)
Clinical Care
Speciality
Clinician
Early to mid career researcher
Senior researcher / scientist
Monday Lunch Live
Research
Treatment Types

This course is brought to you by

Alliance members